GLP-1 Receptor Agonist Use Associated with a Significantly Lower Short-Term Incidence of Obesity-Associated Cancers Among Obese Individuals Without Diabetes By Ogkologos - July 13, 2026 105 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a large real-world cohort Source RELATED ARTICLESMORE FROM AUTHOR Perioperative Durvalumab Plus FLOT Improves OS in Patients with Resectable Gastric or GEJ Adenocarcinoma Advancing Childhood Cancer Research: A Conversation with Dr. Brigitte Widemann Azacitidine-Venetoclax Prolongs EFS Over Induction Chemotherapy Among Induction-Eligible Patients with AML MOST POPULAR EMA Recommends Granting a Marketing Authorisation for Capmatinib May 13, 2022 Dr Ian Walker on Smoking: ‘A political no-brainer’ March 24, 2023 Taking on DNA repair to tackle cancer November 5, 2021 Fourth Vaccine Dose Increases in Humoral Immunity Against Omicron Variants in... October 3, 2022 Load more HOT NEWS Curbing Production of Immune Checkpoint Protein Slows Liver Cancer in Mice Keeping progress in oncology on the agenda: ESMO honours recipients of... How Anxiety Impacts People With Cancer and How to Cope Young District Attorney Diagnosed with Breast Cancer Encourages Others to Get...
